Ensysce Biosciences, Inc. (ENSC) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $5.07M | -2.8% |
| 2024 | $5.21M | +133.6% |
| 2023 | $2.23M | -11.6% |
| 2022 | $2.52M | -28.5% |
| 2021 | $3.53M | -10.2% |
| 2020 | $3.93M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $5.07M | -2.8% |
| 2024 | $5.21M | +133.6% |
| 2023 | $2.23M | -11.6% |
| 2022 | $2.52M | -28.5% |
| 2021 | $3.53M | -10.2% |
| 2020 | $3.93M | — |